retatrutide parkinson disease clinical trial Update on Parkinson's therapies in the clinical
Description
Over 12 months, the liraglutide group also reported an 18% slower decline in cognitive function when compared with the placebo group in the study
Im eating because I need to nourish my body
The limits of the study Among the study's limitations: It was conducted within the VA health system, which serves a population that is mostly older, white and male, although Al-Aly said the results were consistent in more than 35,000 women
At TAPI, weve turned this into an opportunity
Pharma Now has not independently verified all claims in the underlying reporting.
The company states this evaluation typically happens within 24 hours
